BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10441502)

  • 1. Characterization of liposomes carrying von Willebrand factor-binding domain of platelet glycoprotein Ibalpha: a potential substitute for platelet transfusion.
    Kitaguchi T; Murata M; Iijima K; Kamide K; Imagawa T; Ikeda Y
    Biochem Biophys Res Commun; 1999 Aug; 261(3):784-9. PubMed ID: 10441502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of liposomes carrying recombinant fragments of platelet membrane glycoprotein Ibalpha to immobilized von Willebrand factor under flow conditions.
    Nishiya T; Murata M; Handa M; Ikeda Y
    Biochem Biophys Res Commun; 2000 Apr; 270(3):755-60. PubMed ID: 10772897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic truncation of glycoprotein Ib alpha weakens its interaction with von Willebrand factor and impairs cell adhesion.
    Schade AJ; Arya M; Gao S; Diz-Küçükkaya R; Anvari B; McIntire LV; López JA; Dong JF
    Biochemistry; 2003 Feb; 42(7):2245-51. PubMed ID: 12590614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crotalin, a vWF and GP Ib cleaving metalloproteinase from venom of Crotalus atrox.
    Wu WB; Peng HC; Huang TF
    Thromb Haemost; 2001 Dec; 86(6):1501-11. PubMed ID: 11776320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V.
    Kang M; Wilson L; Kermode JC
    Blood Cells Mol Dis; 2008; 40(3):433-43. PubMed ID: 17977030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism.
    Ulrichts H; Vanhoorelbeke K; Cauwenberghs S; Vauterin S; Kroll H; Santoso S; Deckmyn H
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1302-7. PubMed ID: 12775575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A G-quartet oligonucleotide blocks glycoprotein Ib-mediated platelet adhesion and aggregation under flow conditions.
    Zhou Z; Bernardo A; Zhu Q; Guan Y; Sun W; Lopez JA; Jing N; Dong JF
    Thromb Haemost; 2009 Sep; 102(3):529-37. PubMed ID: 19718474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytoplasmic domain of glycoprotein (GP) Ibalpha constrains the lateral diffusion of the GP Ib-IX complex and modulates von Willebrand factor binding.
    Dong JF; Li CQ; Sae-Tung G; Hyun W; Afshar-Kharghan V; López JA
    Biochemistry; 1997 Oct; 36(41):12421-7. PubMed ID: 9376345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mucin-like macroglycopeptide region of glycoprotein Ibalpha is required for cell adhesion to immobilized von Willebrand factor (VWF) under flow but not for static VWF binding.
    Li CQ; Dong JF; López JA
    Thromb Haemost; 2002 Oct; 88(4):673-7. PubMed ID: 12362242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the leucine-rich domain of platelet GPIbalpha in correct post-translational processing--the Nancy I Bernard-Soulier mutation expressed on CHO cells.
    Ulsemer P; Lanza F; Baas MJ; Schwartz A; Ravanat C; Briquel ME; Cranmer S; Jackson S; Cazenave JP; de la Salle C
    Thromb Haemost; 2000 Jul; 84(1):104-11. PubMed ID: 10928479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species.
    Zurbano MJ; Escolar G; Heras M; Ordinas A; Castillo R
    Haematologica; 2000 May; 85(5):514-9. PubMed ID: 10800169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
    Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
    Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of transgenic mice expressing human platelet glycoprotein Ib alpha.
    Kitaguchi T; Murata M; Kuramochi T; Kobayashi K; Ito M; Ueyama Y; Nomura T; Hikichi K; Miyakawa Y; Handa M; Hiraoka Y; Aiso S; Ikeda Y
    Biochem Biophys Res Commun; 1996 Mar; 220(2):418-24. PubMed ID: 8645320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex.
    Graham SS; Gonchoroff NJ; Miller JL
    Am J Clin Pathol; 2001 Jan; 115(1):144-7. PubMed ID: 11190800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?
    Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L
    Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the amino-terminal domain of platelet glycoprotein Ib alpha: exploitation of a calmodulin tag for determination of its functional activity.
    Li CQ; Ye P; Cao Zf ; Wang H; Lu L; Nicastro P; Wood E; Robert JJ; Ouwehand WH; Hill F; López JA; Wardell MR
    Protein Expr Purif; 2001 Jul; 22(2):200-10. PubMed ID: 11437595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.